magneticvc.com Open in urlscan Pro
104.196.15.87  Public Scan

Submitted URL: http://magneticvc.com/
Effective URL: https://magneticvc.com/
Submission: On October 19 via api from US — Scanned from DE

Form analysis 1 forms found in the DOM

GET https://magneticvc.com/

<form role="search" method="get" class="et-search-form" action="https://magneticvc.com/">
  <input type="search" class="et-search-field" placeholder="Search …" value="" name="s" title="Search for:">
</form>

Text Content

 * About
 * Team
 * Portfolio
 * News
 * Contact

Select Page
 * About
 * Team
 * Portfolio
 * News
 * Contact




WE HELP VISIONARY FOUNDERS BUILD CATEGORY-DEFINING HEALTHCARE COMPANIES.

We are driven by respect for the bold entrepreneurs who wake up every morning
with the same goal as Magnetic – to improve patients’ lives. With more than 25
years of multifaceted experience at large pharmaceutical and diagnostic
companies, start-ups, and as investors, we respect the company building process
and are here for our founders, every step of the way.


WE UNDERSTAND THE COMPLEX WORLD OF HEALTHCARE.

With regulatory and market dynamics unique to the sector, we know how to
navigate these complexities and understand the entire lifecycle of healthcare –
from discovery, to regulatory, through commercialization. During our decades in
the industry, we’ve sat in FDA meetings, negotiated business development deals,
and have launched and scaled some of the most ground-breaking technologies and
companies in the sector.


PORTFOLIO

View Our Portfolio ›
Using active-graph machine learning (ML) combined with single-cell analysis to
advance therapeutic candidates for diseases with no or few good medicines.
Unlocking the potential of microfluidics and machine learning to discover
modulators of biomolecular condensates in human disease.
Using cellular barcoding technology to transform clinical decision making in
oncology patients.
Changing the way complex medicines are made and distributed through technology
innovation
Improving healthcare for minority patients through technology-based patient
engagement solutions
Using AI to rapidly accelerate drug discovery and development for rare genetic
diseases


IN THE NEWS

View All ›

ENDPOINTS NEWS

08.15.22


RESILIENCE COLLABORATES WITH THE MAYO CLINIC TO MANUFACTURE RARE AND COMPLEX
DISEASE DRUGS

ENDPOINTS NEWS

06.09.22


EXCLUSIVE: PFIZER VET GRABS $25M SEED ROUND TO ‘INTEGRATE’ MACHINE LEARNING,
GENOMICS TECH IN DRUG R&D (RELATION THERAPEUTICS)

ENDPOINTS NEWS

06.08.22


RESILIENCE NETS ANOTHER DEAL, THIS TIME WITH BILLIONAIRE’S CANCER RESEARCH
CENTER

BLOOMBERG

06.06.22


RESILIENCE ANNOUNCES $625 MILLION SERIES D FINANCING TO EXPAND NETWORK, BRING
INNOVATIVE TECHNOLOGIES TO BIOMANUFACTURING

ENDPOINTS NEWS

06.02.22


THE TARGET IS THE SYSTEM: CONDENSATES BIOTECH ASPIRES TO ‘REWRITE THE RULEBOOK’
ON DRUG DISCOVERY (TRANSITION BIO)

 * Home
 * About
 * Team
 * Portfolio
 * News
 * Contact

©2022 Magnetic Ventures. All rights reserved.